Adze Biotechnology Inc

Amendment
CIK: 0001787508·Biotechnology·DELAWARE·Filed: Nov 19, 2021
Total Offering

$4,057,500

Amount Sold

$2,557,500

Investors

9

First Sale

Dec 12, 2019

Offering Details

Type
Equity, Debt, Security to be Acquired
Exemptions
Rule 506(c)
Entity Type
Corporation
Year Incorporated
2019
Non-Accredited Investors
No

Related Persons

NameRole
Sidney Hopps
Related Person
Kenneth Templin
Related Person
Richard Schuler
Related Person
Patrick G. Sage, II
Related Person
Gabriel Raviv
Related Person

Company

Adze Biotechnology Inc

805 LAKE STREET, #126

OAK PARK, IL, 60301

9177439401

SEC Filing

0001787508-21-000002

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free